Medicare Enrolled
Dr. Dianne Cooper, M.D.
Rheumatology · Wichita Falls, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cooper from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cooper?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cooper
Dr. Dianne Cooper is a rheumatology specialist in Wichita Falls, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cooper performed 173,434 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Cooper received a total of $235,633 from 44 pharmaceutical and/or device companies across 1556 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cooper is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 6% volume in TX
$235,633 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗173,434
Medicare services
Top 6% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 89,511 | $5 | $9 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
19,920 | $10 | $57 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
13,700 | $34 | $65 |
| Denosumab injection (Prolia/Xgeva) | 13,560 | $18 | $28 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
11,320 | $25 | $142 |
| Belimumab injection, 10 mg An injection of belimumab, a medication administered at a dose of 10 mg. |
11,314 | $40 | $110 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
5,500 | $63 | $152 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
1,781 | $0 | $20 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,560 | $10 | $48 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
999 | $91 | $223 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
859 | $63 | $149 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
540 | $95 | $350 |
| Injection, methylprednisolone acetate, 40 mg | 424 | $6 | $45 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
375 | $11 | $38 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
357 | $1 | $1 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
352 | $47 | $145 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
345 | $20 | $80 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
300 | $1 | $10 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
216 | $0 | $2 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
145 | $4 | $10 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
88 | $1 | $2 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
77 | $16 | $45 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
69 | $49 | $169 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
32 | $19 | $34 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
28 | $31 | $90 |
| New patient office visit, complex (60-74 min) | 23 | $144 | $446 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
15 | $9 | $45 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
12 | $37 | $128 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
12 | $26 | $130 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
26.4% high complexity
72.4% medium
1.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$235,633
Total received (2018-2024)
Avg $33,662/year across 7 years
Top 4% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
1,556
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$28,836
2023
$44,666
2022
$26,460
2021
$28,702
2020
$27,608
2019
$40,493
2018
$38,870
Payments by company (2024)
GlaxoSmithKline, LLC.
$14,069
Amgen Inc.
$12,466
ABBVIE INC.
$462
UCB, Inc.
$341
ANI Pharmaceuticals, Inc.
$307
Janssen Biotech, Inc.
$222
AstraZeneca Pharmaceuticals LP
$219
PFIZER INC.
$153
Novartis Pharmaceuticals Corporation
$94
Lilly USA, LLC
$91
Radius Health, Inc.
$85
Novo Nordisk Inc
$72
E.R. Squibb & Sons, L.L.C.
$49
DePuy Synthes Sales Inc.
$41
SI-BONE, INC.
$37
Janssen Scientific Affairs, LLC
$33
Fresenius Kabi USA, LLC
$27
Sandoz Inc.
$20
Almatica Pharma LLC
$20
Genentech USA, Inc.
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Top 3 companies account for 93.6% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$105,189
Amgen Inc.
$46,180
Janssen Scientific Affairs, LLC
$26,641
Celgene Corporation
$25,202
Horizon Therapeutics plc
$8,515
UCB, Inc.
$4,944
Ironwood Pharmaceuticals, Inc
$3,499
Janssen Biotech, Inc.
$3,118
E.R. Squibb & Sons, L.L.C.
$1,618
PFIZER INC.
$1,362
AbbVie Inc.
$1,224
Genentech USA, Inc.
$1,090
AstraZeneca Pharmaceuticals LP
$1,045
ABBVIE INC.
$948
Lilly USA, LLC
$870
GENZYME CORPORATION
$846
Radius Health, Inc.
$649
Novartis Pharmaceuticals Corporation
$584
ANI Pharmaceuticals, Inc.
$473
AbbVie, Inc.
$279
Takeda Pharmaceuticals U.S.A., Inc.
$170
Boehringer Ingelheim Pharmaceuticals, Inc.
$168
Horizon Pharma plc
$137
Lundbeck LLC
$109
Mallinckrodt LLC
$106
Sobi, Inc
$83
Novo Nordisk Inc
$72
DePuy Synthes Sales Inc.
$70
SANOFI-AVENTIS U.S. LLC
$65
Daiichi Sankyo Inc.
$56
Zyla Life Sciences
$51
Exeltis, USA Inc.
$37
SI-BONE, INC.
$37
Fresenius Kabi USA, LLC
$27
Flexion Therapeutics, Inc.
$27
Sandoz Inc.
$20
Almatica Pharma LLC
$20
Aurinia Pharma U.S., Inc.
$19
Purdue Pharma L.P.
$17
US WorldMeds, LLC
$15
Cumberland Pharmaceuticals, Inc.
$13
IRONWOOD PHARMACEUTICALS, INC
$13
Assertio Therapeutics, Inc.
$12
Zyla Life Sciences, Inc.
$12
Top 3 companies account for 75.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · BENLYSTA · Bimzelx · CHANTIX · COSENTYX · CUVITRU · CYLTEZO · Cimzia · DUZALLO · EVENITY · EVUSHELD · Enbrel · FORTEO · HUMIRA · HYRIMOZ · HYSINGLA ER · Humira · IDACIO · INJECTAFER · KEVZARA · KINERET · KRYSTEXXA · LINZESS · LUPKYNIS · LYRICA · Linzess · Lucemyra/Lofexidine · MONOVISC · Morphabond ER · OFEV · ORENCIA · Otezla · PAXLOVID · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · QULIPTA · RAYOS · REDITREX · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Repatha · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · TALTZ · TAVNEOS · TEPEZZA · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · UBRELVY · Uloric · VYEPTI · XELJANZ · ZORVOLEX · Zilretta · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
4
County median income
$62,168
Nearest hospital to ZIP centroid (approximate)
NORTH TEXAS STATE HOSPITAL
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cooper is a mixed practice specialist, with above-average Medicare volume (top 6% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cooper experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Cooper performed 89,511 tocilizumab injection (actemra) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cooper receive payments from pharmaceutical companies?
Yes. Dr. Cooper received a total of $235,633 from 44 companies across 1,556 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cooper's costs compare to other rheumatologists in Wichita Falls?
Dr. Cooper's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cooper) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Wichita Falls
Browse rheumatologists in Wichita Falls ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology